Coya Therapeutics, Inc. ( (COYA) ) just unveiled an announcement.
Coya Therapeutics has announced a change in leadership with Dr. Arun Swaminathan stepping in as CEO, following Dr. Howard Berman’s resignation. Swaminathan’s new role comes with a base salary of $525,000 and potential bonuses, while Berman transitions to Executive Chairman with an annual salary of $420,000. Both executives are eligible for equity awards and have contracts detailing severance terms, reflecting strategic moves to align leadership incentives with the company’s goals.
For detailed information about COYA stock, go to TipRanks’ Stock Analysis page.
